Pulished Date October, 2018
ID: 284
Share on
Share on

The Pyrogen Testing Market Is Predicted To Reach USD 1555.38 Million With A CAGR Of 13.73% According To Market Data Forecast Report

Pulished: October, 2018
ID: 284
Pages: 0

The Pyrogen Testing Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Pyrogen Testing Market is estimated to be USD 817.45 million and predicted to rise to USD 1555.38 million with a CAGR of 13.73%. The market is segmented by Product (Kits & Reagents, Services, Instruments), by Application (Pharmaceutical and Biological Manufacturing, Medical Device Manufacturing and other applications), and Test Type (LAL Tests, In-Vitro Tests and Rabbit Tests). Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa

Global Pyrogen testing market is expected to show significant growth owing to increasing number of biologic products, rise in chronic disease burden and increasing emphasis on research and development. Increasing government support for the pharmaceutical and biotechnology industries are also aiding in the growth of pyrogen testing market. However stringent regulatory policies and reimbursement issues are restraining the growth of the market. Outsourcing the manufacturing of pharmaceutical products to developing countries provide lucrative growth opportunity due to decreased sunk costs.

North America is the dominating market for Pyrogen testing accounting for a share of approximately XX% owing to an increasing number of new biologics and widespread knowledge about various products and services. Europe is the second largest market for pyrogen testing due to increasing chronic disease burden. Asia-Pacific is estimated to be the fastest growing segment due to its growing population and increasing disposable income.

Some of the major companies discussed in the report are Associates of Cape Cod, Inc., Lonza Group, Merck Kgaa, Ellab A/S, Genscript, Hyglos GmbH, Thermo Fisher Scientific, Inc., Charles River Laboratories, Inc., Wako Chemicals USA, Inc and WUXI Pharmatech (Cayman) Inc.

Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-pyrogen-testing-market-282/” and checkout our recent reports in the Diagnostics category at “http://www.marketdataforecast.com/research-reports/healthcare/diagnostics-5/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.

LICENCE TYPE

$ 1234 0

Clients
clients
clients
clients
clients
clients
clients

Research Areas